U.S. Markets
Pfizer (PFE) CEO says the co. will maintain dividend and resume dividend growth after loss of exclusivity period, via conference call
StockNow breaking-news AI analysis
Pfizer plans to maintain dividends through its 2026–2028 patent cliff, targeting a return to dividend growth and double-digit revenue expansion starting in 2029 via oncology and acquisition-led pipelines.
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
